Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03838159
What this trial is testing

NADIM II: Neo-Adjuvant Immunotherapy

Who this might be right for
Non Small Cell Lung Cancer
Fundación GECP 90
Early research (Phase 1)Study completedNCT06446180
What this trial is testing

Streptococcus Salivarius K12@Lip@GSH Alleviates Oral Mucositis in Patients Undergoing Radiotherapy

Who this might be right for
Oral Mucositis
The General Hospital of Western Theater Command 22
Large-scale testing (Phase 3)UnknownNCT01405079
What this trial is testing

Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 222
Testing effectiveness (Phase 2)UnknownNCT04524208
What this trial is testing

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Carcinoma
Karsten Gavenis 45
Testing effectiveness (Phase 2)UnknownNCT06482008
What this trial is testing

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 33
Not applicableUnknownNCT05233540
What this trial is testing

Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy

Who this might be right for
Anal CancerLocally Advanced Squamous Cell CarcinomaOligometastatic Disease+2 more
Aarhus University Hospital 60
Not applicableLooking for participantsNCT07548268
What this trial is testing

Transoral and Cervical Ultrasound of Patients With Suspected Oropharyngeal Cancer

Who this might be right for
Oropharyngeal CarcinomaUltrasound
Tobias Todsen 180
Not applicableUnknownNCT02904850
What this trial is testing

Validation of a Kinetic Model of Erlotinib

Who this might be right for
Lung Cancer
University Hospital, Strasbourg, France 50
Not applicableStudy completedNCT02080650
What this trial is testing

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Who this might be right for
Prostate CancerRenal Cell CarcinomaBladder Cancer+5 more
Duke University 62
Large-scale testing (Phase 3)Study completedNCT04028050
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Hoffmann-La Roche 155
Testing effectiveness (Phase 2)Study completedNCT03558191
What this trial is testing

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 156
Testing effectiveness (Phase 2)Ended earlyNCT00544674
What this trial is testing

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Proacta, Incorporated 5
Testing effectiveness (Phase 2)UnknownNCT03820310
What this trial is testing

Clinical Trial of Autologous Tcm Immunotherapy in ICC

Who this might be right for
Cholangiocarcinoma
Newish Technology (Beijing) Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT00299390
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 10
Early research (Phase 1)Looking for participantsNCT05172310
What this trial is testing

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Who this might be right for
Pancreatic NeoplasmsStomach NeoplasmsBile Duct Neoplasms+1 more
Karolinska University Hospital 410
Testing effectiveness (Phase 2)Ended earlyNCT04352413
What this trial is testing

PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Not applicableUnknownNCT03914820
What this trial is testing

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study.

Who this might be right for
Colorectal Neoplasms
Mario Negri Institute for Pharmacological Research 330
Testing effectiveness (Phase 2)Study completedNCT04247282
What this trial is testing

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Who this might be right for
Head and Neck CancerHead and Neck Neoplasms
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Active Not RecruitingNCT03842982
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)

Who this might be right for
Ovary NeoplasmsOvarian CancerOvarian Carcinoma
Centre Oscar Lambret 362
Not applicableUnknownNCT05580224
What this trial is testing

Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 87
Next Page